Pharmacokinetics of Etonogestrel and Ethinylestradiol Released from a Combined Contraceptive Vaginal Ring
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
To assess the pharmacokinetics of etonogestrel and ethinylestradiol released from a novel combined contraceptive vaginal ring (NuvaRing®) releasing etonogestrel 120µg and ethinylestradiol 15µg per day and compare them with those of a combined oral contraceptive containing desogestrel 150µg/ethinylestradiol 30µg (DSG/EE COC).
Design and setting
This was a nonblind, randomised, crossover study in 16 healthy women.
All volunteers received one cycle of DSG/EE COC before being randomised to 1 of 2 treatment groups. The participants in group 1 received 1 cycle of DSG/EE COC, a treatment period with NuvaRing® and an intravenous bolus injection of etonogestrel/ethinylestradiol (150µg/30µg). Those in group 2 received a NuvaRing® treatment period, 1 cycle of DSG/EE COC and the same intravenous bolus injection.
Results and conclusions
After the insertion of NuvaRing®, maximum serum concentrations of etonogestrel and ethinylestradiol were achieved in approximately 1 week. The concentrations subsequently showed a gradual linear decrease in time. The maximum serum concentrations of etonogestrel and ethinylestradiol were approximately 40 and 30%, respectively, of those for the DSG/EE COC. In comparison with the DSG/EE COC, the absolute bioavailability for NuvaRing® was higher for etonogestrel (102.9 vs 79.2%) and similar for ethinylestradiol (55.6 vs 53.8%). Taking the difference in daily doses into account, systemic exposure to etonogestrel was similar for NuvaRing® and the DSG/EE COC, whereas systemic exposure to ethinylestradiol with NuvaRing®was only approximately 50% of that for the DSG/EE COC.
- Mishell, D.R., Talas, M., Parlow, A.F. (1970) Contraception by means of a Silastic vaginal ring impregnated with medroxyprogesterone acetate. Am J Obstet Gynecol 107: pp. 100-7
- Odlind, V. (1986) New delivery systems for hormonal contraception. Acta Obstet Gynecol Scand Suppl 134: pp. 15-20 CrossRef
- Leede, L.G.J., Govers, C.P.M., Nijs, H. (1986) A multicompartment vaginal ring system for independently adjustable release of contraceptive steroids. Contraception 34: pp. 589-602 CrossRef
- Newton, J.R. (1995) Classification and comparison of oral contraceptives containing new generation progestogens. Hum Reprod Update 1: pp. 231-63 CrossRef
- Hammond, G.L., Bocchinfuso, W.P., Orava, M. (1994) Serum distribution of two contraceptive progestins: 3-ketodesogestrel and gestodene. Contraception 50: pp. 301-18 CrossRef
- Petak, S.M., Steinberger, E. The adrenal gland. In: Goldzieher, J.W. eds. (1994) Pharmacology of the contraceptive steroids. Raven Press, New York, pp. 233-42
- Pharmacokinetics of Etonogestrel and Ethinylestradiol Released from a Combined Contraceptive Vaginal Ring
Volume 39, Issue 3 , pp 233-242
- Cover Date
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Industry Sectors